Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Summary

This randomized trial studies transdermal or oral telapristone acetate in treating patients undergoing surgery to remove the breast (mastectomy). Telapristone acetate may help prevent breast cancer from forming in premenopausal women. Giving telapristone acetate transdermally may be safer and have fewer side effects than oral administration.

Timeline

Start

2015-10

Primary completion

2018-01

Completion

2021-05

Drugs

Indications